Discover the limitations of Net Present Value (NPV) in evaluating investments, including challenges in choosing an accurate discount rate and potential missed opportunities.
Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, speaks at the Informa Biotech Showcase during JP Morgan week. One month ago, the FDA approved two gene therapies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results